Published in Vaccine Weekly, May 15th, 2002
H. Shinefield of the Kaiser Permanente Vaccine Study Center, Oakland, California and colleagues followed 37,868 infants enrolled in a randomized double blind clinical trial to compare the safety, efficacy, and immunogenicity of the PCV and MCV. Of the total number of children, 1756 were identified as low birth weight (between 750 and 2500 g) and 4340 classified as preterm (32 to 38...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly